Active surveillance is a globally recognized standard approach for patients with low - risk prostate cancer and select intermediate - risk patients with prostate cancer. (sciencedaily.com)
This has the potential to be a less toxic and more effective treatment than more standard approaches because it can specifically target cancer cells. (sciencedaily.com)
Standard approaches also struggle to find combinations of multiple genes that affect disease risk in complex ways (known as genetic interactions). (sciencedaily.com)